Advertisement
Screener

Keros Therapeutics, Inc. (KROS) Net Margin

Keros Therapeutics, Inc. (KROS) Net Margin

  • 2026-03-31: Net Margin -6459.95%.
  • 2025-12-31: Net Margin -6093.77%.
  • 2025-09-30: Net Margin -51.04%.
  • 2025-06-30: Net Margin -168.96%.

Complete source-backed net margin history.

Available history
2019-03-31 to 2026-03-31
Data captured

Historical Net Margin

DateNet Margin
2026-03-31-6459.95%
2025-12-31-6093.77%
2025-09-30-51.04%
2025-06-30-168.96%
2025-03-3170.27%
2024-12-31-1513.02%
2024-09-30-13648.45%
2024-06-30-122316.22%
2024-03-31-51944.58%
2023-12-31-28141.96%
2023-09-30-493000.00%
2021-12-31-34.70%
2021-06-30-15622.00%
2019-12-31-110.04%
2019-09-30-141.96%
2019-06-30-114.12%
2019-03-31-127.32%

Annual Net Margin

DateNet Margin
2025-12-3135.65%
2024-12-31-5277.55%
2023-12-31-101319.21%
2021-12-31-292.26%
2019-12-31-123.36%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73